Camp4 Therapeutics (CAMP) director awarded 28,000 stock options at $4.34 strike

Rhea-AI Filing Summary

Camp4 Therapeutics Corp director Stewart Murray received a grant of stock options covering 28,000 shares of Common Stock. The options have an exercise price of $4.34 per share and expire on June 9, 2036.

The 28,000 underlying shares vest in full on the earlier of the first anniversary of the grant date or the company’s next annual meeting of stockholders, provided Murray continues service with Camp4 Therapeutics through that vesting date. Following this grant, his directly held option position reported in this filing is 28,000 options.

Insights

Equity compensation analyst

Routine director stock option grant aligns compensation with share performance.

Director Stewart Murray received 28,000 stock options for Camp4 Therapeutics Common Stock with a $4.34 exercise price, expiring in 2036. This award is compensation-related, not an open-market trade, and therefore carries limited signaling value about near-term stock expectations.

The options vest fully on the earlier of the first anniversary of the grant date or the next annual meeting of stockholders, subject to continued service. This structure encourages board continuity and longer-term alignment, while leaving actual economic benefit dependent on future stock performance above the exercise price.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Stewart Murray

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	28,000	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 28,000 shares (Direct)

Footnotes (1)

1. F1. The shares underlying the option vest in their entirety on the earlier of the first anniversary of the grant date or the date of the issuer's next annual meeting of stockholders, subject to continued service to the Company through the applicable vesting date.

Key Figures

Option grant size: 28,000 options Exercise price: $4.34 per share Underlying shares: 28,000 shares +2 more

5 metrics

Option grant size 28,000 options Stock Option (Right to Buy) granted to director

Exercise price $4.34 per share Conversion or exercise price of options

Underlying shares 28,000 shares Common Stock underlying granted options

Expiration date June 9, 2036 Option term end date

Post-grant option holdings 28,000 options Total derivative securities following transaction

Key Terms

Stock Option (Right to Buy), exercise price, vest, annual meeting of stockholders

4 terms

Stock Option (Right to Buy) financial

"security_title: Stock Option (Right to Buy)"

exercise price financial

"conversion_or_exercise_price of 4.3400 per share"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vest financial

"The shares underlying the option vest in their entirety"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

annual meeting of stockholders financial

"earlier of the first anniversary of the grant date or the date of the issuer's next annual meeting of stockholders"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/12/2026 - 04:16 PM Accepted by SEC EDGAR 06/12/2026 - 04:15 PM Learn about SEC filing dates

FAQ

What did Camp4 Therapeutics (CAMP) director Stewart Murray receive in this Form 4?

Stewart Murray received a grant of stock options for 28,000 shares of Camp4 Therapeutics Common Stock. These options are part of his director compensation and give him the right to buy shares at a fixed exercise price if the stock performs well over time.

What is the exercise price and expiration for Stewart Murray’s Camp4 (CAMP) options?

The options granted to Stewart Murray have an exercise price of $4.34 per share and expire on June 9, 2036. He can choose to exercise them any time after vesting and before expiration if Camp4’s stock trades above the exercise price.

How and when do Stewart Murray’s Camp4 (CAMP) stock options vest?

All 28,000 options vest in their entirety on the earlier of the first anniversary of the grant date or Camp4’s next annual meeting of stockholders. Vesting is conditional on Murray continuing to provide service to the company through the applicable vesting date.

Does this Camp4 (CAMP) Form 4 show a stock purchase or sale by Stewart Murray?

No open-market purchase or sale is reported. The Form 4 shows an acquisition of 28,000 stock options as a grant, not a cash transaction in the market. It reflects compensation rather than a discretionary trade in existing Camp4 shares.

How many Camp4 (CAMP) options does Stewart Murray hold after this transaction?

After the grant, Stewart Murray’s directly held position reported in this filing is 28,000 stock options. Each option corresponds to one share of Camp4 Therapeutics Common Stock, potentially giving him future ownership if he exercises them at or above the $4.34 exercise price.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Stewart Murray

(Last) (First) (Middle)

C/O CAMP4 THERAPEUTICS CORPORATION

ONE KENDALL SQ., BLDG 1400 WEST, 3RD FL.

(Street)

CAMBRIDGE MASSACHUSETTS 02139

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Camp4 Therapeutics Corp [ CAMP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$4.34	06/10/2026		A		28,000		(1)	06/09/2036	Common Stock	28,000	$0	28,000	D

Explanation of Responses:

1. The shares underlying the option vest in their entirety on the earlier of the first anniversary of the grant date or the date of the issuer's next annual meeting of stockholders, subject to continued service to the Company through the applicable vesting date.

Remarks:

	/s/ Josh Mandel-Brehm, as Attorney-in-Fact	06/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)